2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (


Journal

Bioanalysis
ISSN: 1757-6199
Titre abrégé: Bioanalysis
Pays: England
ID NLM: 101512484

Informations de publication

Date de publication:
Mar 2021
Historique:
pubmed: 4 2 2021
medline: 30 11 2021
entrez: 3 2 2021
Statut: ppublish

Résumé

The 14

Identifiants

pubmed: 33533276
doi: 10.4155/bio-2021-0007
doi:

Substances chimiques

Receptors, Chimeric Antigen 0
Vaccines 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-463

Auteurs

Bart Corsaro (B)

GlaxoSmithKline, Rockville, MD, USA.

Tong-Yuan Yang (TY)

Janssen R&D, Spring House, PA, USA.

Rocio Murphy (R)

Merck, West Point, PA, USA.

Ivo Sonderegger (I)

Takeda, Opfikon, Switzerland.

Andrew Exley (A)

UK MHRA, London, UK.

Sylvie Bertholet (S)

GlaxoSmithKline, Rockville, MD, USA.

Naveen Dakappagari (N)

Navigate, a Novartis Subsidiary, San Diego, CA, USA.

Francis Dessy (F)

GlaxoSmithKline, Rixensart, Belgium.

Fabio Garofolo (F)

BRI, Vancouver, BC, Canada.

Lisa Kierstead (L)

PPD, Wayne, PA, USA.

Holger Koch (H)

Takeda, Opfikon, Switzerland.

Ghanashyam Sarikonda (G)

Navigate, a Novartis Subsidiary, San Diego, CA, USA.

Natasha Savoie (N)

CFABS, Montreal, QC, Canada.

Richard Siggers (R)

Health Canada, Ottawa, ON, Canada.

Therese Solstad (T)

Norwegian Medicines Agency, Oslo, Norway.

Yanmei Lu (Y)

Sangamo Therapeutics, Brisbane, CA, USA.

Mark Milton (M)

Novartis, Cambridge, MA, USA.

Jean-Claude Marshall (JC)

Pfizer, Groton, CT, USA.

Jason DelCarpini (J)

bluebird bio, Cambridge, MA, USA.

Boris Gorovits (B)

Pfizer, Andover, MA, USA.

Swati Gupta (S)

Abbvie, Irvine, CA, USA.

Lynne Jesaitis (L)

BioMarin, Novato, CA, USA.

John Kamerud (J)

Pfizer, Andover, MA, USA.

Arno Kromminga (A)

BioAgilytix, Hamburg, Germany.

Anna Ma (A)

CRISPR Therapeutics, Cambridge, MA, USA.

Jim McNally (J)

BioAgilytix, Durham, NC, USA.

Haoheng Yan (H)

US FDA, Silver Spring, MD, USA.

Bonnie Wu (B)

Janssen R&D, Spring House, PA, USA.

Daniela Verthelyi (D)

US FDA, Silver Spring, MD, USA.

Susan Kirshner (S)

US FDA, Silver Spring, MD, USA.

Joao Pedras-Vasconcelos (J)

US FDA, Silver Spring, MD, USA.

Manoj Rajadhyaksha (M)

Regeneron Pharmaceuticals, Tarrytown, NY, USA.

Roland F Staack (RF)

Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany.

Elana Cherry (E)

Health Canada, Ottawa, ON, Canada.

Isabelle Cludts (I)

UK MHRA-NIBSC, London, UK.

Madeleine Dahlbäck (M)

Novo Nordisk, Maaloev, Denmark.

George R Gunn (GR)

GlaxoSmithKline, Collegeville, PA, USA.

Akiko Ishii-Watabe (A)

Japan MHLW-NIHS, Tokyo, Japan.

Vibha Jawa (V)

Merck, Kenilworth, NJ, USA.

Robert Kubiak (R)

AstraZeneca, Gaithersburg, MD, USA.

Michael Partridge (M)

Regeneron Pharmaceuticals, Tarrytown, NY, USA.

Marco Petrillo (M)

Biogen, Cambridge, MA, USA.

Samuel O Pine (SO)

Ablynx, Zwijnaarde, Belgium.

Johann Poetzl (J)

Hexal AG, Oberhaching, Germany.

Sam Song (S)

Takeda, Cambridge, MA, USA.

Chris Stebbins (C)

Immunologix Labs, Tampa, FL, USA.

Yuling Wu (Y)

AstraZeneca, Gaithersburg, MD, USA.

Lucia Zhang (L)

Health Canada, Ottawa, ON, Canada.

Sumit Kar (S)

CFABS, Montreal, QC, Canada.

Meina Liang (M)

AstraZeneca, South San Francisco, CA, USA.

Mohsen Rajabi Abhari (MR)

US FDA, Silver Spring, MD, USA.

Becky Schweighardt (B)

BioMarin, Novato, CA, USA.

Kay Stubenrauch (K)

Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany.

Yuanxin Xu (Y)

Intellia Therapeutics, Cambridge, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH